| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WDR61 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | RAB38 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | TDP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | SLC24A5 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | RFK | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | NR0B1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | RDH13 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | CBR1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
